G1 Therapeutics
A company developing small molecule therapies to treat cancer
All edits by Damien Anderson
Edits on 30 Apr, 2019
Damien Anderson
Edits made to:
Article (+18/-18 characters)
Article
On October 16, 2013 G1 Therapeutics completed their series A funding round with $12.5 million in funding from MedImmune VenturesMedImmune Ventures (lead investor), Mountain Group Capital, and Hatteras Venture Partners.
Find more companies like G1 Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.